VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CLX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CLXThe Clorox Company
$99.96$12.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. CLX
  4. Financial Ratios

The Clorox Company (CLX) Financial Ratios

Latest Ratios: P/E Ratio 18.0x · EV/EBITDA 8.4x · ROE 159.9%. (1997–2026 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

CLX Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Market Cap$12.1B$11.7B$14.9B$17.0B$19.7B$17.5B$22.9B$28.0B$19.9B$17.8B$17.5B
Enterprise Value$17.5B$17.0B$17.6B$19.7B$22.3B$20.4B$25.7B$30.3B$22.4B$20.1B$19.3B
P/E Ratio →18.0219.8418.4260.65132.5337.8032.2429.8524.2321.6425.00
P/S Ratio1.681.732.102.402.672.463.124.173.202.912.93
P/B Ratio48.4546.2630.9634.6250.9023.9638.6930.8435.5524.5132.34
P/FCF26.6828.7819.6135.2621.2432.6524.2421.6825.2822.8227.52
P/OCF19.7519.0515.2124.5117.0622.2217.9518.1220.0318.2720.20

P/E links to full P/E history page with 30-year chart

CLX EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
EV / Revenue—2.532.482.783.022.873.514.503.613.293.23
EV / EBITDA8.458.9212.6320.6021.0621.6217.9321.0017.4415.6115.08
EV / EBIT10.5118.4915.1340.4468.0128.6025.7823.5720.0217.6917.22
EV / FCF—42.0623.1740.8623.9938.1127.2523.4228.5625.8330.31

CLX Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Gross Margin42.3%42.3%45.2%43.0%39.4%35.8%43.6%45.6%43.9%43.7%44.7%
Operating Margin24.7%24.7%16.6%10.2%11.1%10.1%16.7%18.8%17.8%18.4%18.7%
Net Profit Margin8.7%8.7%11.4%3.9%2.0%6.5%9.7%14.0%13.2%13.4%11.7%

Return on Capital

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
ROE159.9%159.9%166.3%63.6%26.7%69.9%94.7%128.0%127.6%129.8%167.1%
ROA8.8%8.8%14.3%4.8%2.5%7.4%11.3%16.6%16.1%17.1%15.4%
ROIC28.3%28.3%27.6%17.7%18.7%15.2%27.8%30.1%26.7%31.3%37.0%
ROCE38.4%38.4%30.1%17.6%19.6%16.6%27.0%29.8%29.4%34.0%39.0%

CLX Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Debt / Equity21.9021.905.985.907.544.265.353.444.803.424.05
Debt / EBITDA2.892.892.063.032.763.292.202.172.081.921.71
Net Debt / Equity—21.345.635.496.594.014.812.484.603.243.28
Net Debt / EBITDA2.822.821.942.822.413.101.981.562.001.821.39
Debt / FCF—13.283.575.592.755.463.011.743.273.022.79
Interest Coverage7.087.0813.255.423.646.7310.0912.9711.5613.4012.74

CLX Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Current Ratio0.660.660.841.030.950.970.891.420.911.090.84
Quick Ratio0.380.380.570.630.590.540.521.100.550.670.58
Cash Ratio0.050.050.090.130.190.100.160.610.080.110.23
Asset Turnover—0.861.281.231.241.151.161.081.211.211.31
Inventory Turnover4.994.997.446.356.446.045.518.066.816.827.19
Days Sales Outstanding—42.9642.1835.7633.9934.9730.0335.1937.0635.7634.53

CLX Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Dividend Yield4.9%5.2%4.0%3.5%3.0%3.3%2.4%1.9%2.5%2.5%2.4%
Payout Ratio102.6%102.6%74.3%212.5%391.3%123.6%78.6%56.8%59.8%54.7%58.8%

Total Shareholder Return Metrics

MetricTTMFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Earnings Yield5.6%5.0%5.4%1.6%0.8%2.6%3.1%3.4%4.1%4.6%4.0%
FCF Yield3.7%3.5%5.1%2.8%4.7%3.1%4.1%4.6%4.0%4.4%3.6%
Buyback Yield2.1%2.2%2.2%0.0%0.0%0.1%4.0%0.9%3.3%1.5%1.0%
Total Shareholder Yield7.0%7.4%6.3%3.5%3.0%3.4%6.4%2.8%5.8%4.1%3.4%
Shares Outstanding—$122M$124M$125M$124M$124M$127M$128M$130M$132M$132M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Elevated leverage amid cyber recovery

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q1)

Defensive Premium Stretched by Thin Equity

Based on reported figures, CLX trades at 15.29x trailing earnings and 10.58x trailing EV/EBITDA, a discount to Church & Dwight's 36.86x P/E and 21.26x EV/EBITDA that appears to reflect weaker growth durability rather than a pure defensive premium. The 25.71x price-to-book multiple is inflated by near-zero equity rather than by asset quality, so earnings-based multiples carry more weight here.

The gap to CHD suggests the market is pricing CLX as a lower-growth household staples name, consistent with volume softness in the core bleach and wipes franchise over recent quarters. A forward P/E of 18.06x implies modest expected earnings growth, which appears reasonable but leaves little margin for execution slippage. Using P/B as an anchor would be misleading given shareholders' equity of only about $90M, so EV/EBITDA and FCF yield offer a cleaner read on what the market is paying for operating cash generation.

Margin Recovery Masks Earnings Volatility

As reported in quarterly statements, CLX gross margin has held in a 40.4% to 46.5% band, yet operating margin swung from 8.4% to 52.5% across ten quarters, a range that appears driven by non-recurring items rather than steady operating scaling. The latest 13.7% operating margin is the more representative figure for underlying earnings power, and net margin of 8.9% sits below the 11.9% reported by CHD.

The stability of gross margin relative to the extreme swings in operating and net margin suggests that below-the-line items, including cyber remediation and insurance recoveries, are distorting reported profitability. An operating margin around 14% appears to be a more defensible run-rate than the headline 52.5% quarter, which likely reflects a one-time benefit. The persistent gap between gross and net margin also indicates that SG&A and interest costs absorb a large share of gross profit, which warrants monitoring given the leverage load.

Headline ROE Flattered by Shrunken Equity

According to reported filings, CLX ROE has printed between 2.9% and 181.5% over ten quarters, while ROIC has stayed in a more stable 2.9% to 17.0% range, suggesting ROE is distorted by a minimal equity base. The latest ROIC of 3.5% is well below the 13.9% reported by Church & Dwight, and returns appear to be compressing rather than compounding.

The ROE spikes primarily reflect a balance sheet with minimal or negative equity rather than any genuine improvement in shareholder economics, so ROIC is the more meaningful gauge. The latest ROIC reading of 3.5% indicates that capital deployed into goodwill and acquired brands, including the VMS portfolio, is not generating returns near historical levels. Investors should watch whether ROIC recovers toward the mid-to-high single digits as recovery effects fade.

Debt Load Outpaces Interest Coverage Comfort

Based on reported figures, CLX debt-to-EBITDA has ranged from 6.0x to 17.5x across recent quarters, with the latest reading near 16.7x, while interest coverage sits at 4.98x. Total debt rose from roughly $2.9B to about $5.6B over the window against cash near $184M, a profile materially heavier than the 0.55 debt-to-equity reported by CHD.

Interest coverage near 5x provides a workable cushion for now, but the debt-to-EBITDA trajectory suggests that earnings volatility could quickly compress that margin of safety. The thin cash balance relative to roughly $5.6B of debt raises refinancing sensitivity if rates remain elevated. Investors should monitor whether management prioritizes deleveraging over shareholder returns, as the current capital structure leaves limited flexibility.

Sub-Parity Current Ratio Constrains Buffer

As reported in the quarterly statements, CLX current ratio has ranged from 0.65 to 1.03 and sits near 0.65 in the latest quarter, while the quick ratio is about 0.39, meaning current liabilities exceed current assets. The cash conversion cycle of roughly negative 33 days suggests supplier financing is funding working capital.

A negative cash conversion cycle means CLX collects from customers and pays suppliers on terms that effectively fund operations, which is typical of scale consumer staples but becomes fragile if supplier terms tighten. The quick ratio of 0.39 indicates heavy reliance on inventory and receivables to meet obligations. Under severe stress, such as a sudden loss of supplier credit or a demand shock, the balance sheet would likely require external financing or dividend restraint.

Lagging Returns Versus Structural Peer Gaps

Based on reported peer data, CLX trails Church & Dwight on ROIC at 3.5% versus 13.9% and on net margin at 8.9% versus 11.9%, while its debt-to-equity is far higher. CLX offers a higher dividend yield of 4.9% against CHD's 1.1%, and the return gap appears more structural than cyclical given the leverage and goodwill base.

The ROIC shortfall relative to CHD suggests CLX is deploying capital into lower-return assets, including acquired intangibles, while CHD has sustained higher returns through a more focused portfolio. The dividend yield premium likely reflects the market pricing CLX as a more levered, lower-growth income vehicle. Whether these gaps close depends on whether CLX can restore margin and ROIC without further leverage.

Cyber Recovery May Flatter Trailing Returns

Based on reported filings, CLX's trailing profitability may be inflated by recovery dynamics following the 2023 cybersecurity incident, with the 52.5% operating margin quarter likely reflecting one-time benefits rather than run-rate economics. The most commonly misapplied metric here is ROE, which the reported equity base distorts.

Return on equity is the ratio most often misapplied to CLX because shareholders' equity has been near zero or negative across much of the window, which mechanically inflates ROE into the triple digits. A more reliable approach is to anchor on ROIC and cash-based measures such as free cash flow margin, adjusted for remediation costs and insurance recoveries. Investors should treat the latest ROIC of 3.5% as the more honest view of capital efficiency until recovery effects clearly fade.

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus & Technical Research Suite
Open CLX Terminal

CLX Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CLX — Frequently Asked Questions

Quick answers to the most common questions about buying CLX stock.

What is The Clorox Company's P/E ratio?

The Clorox Company's current P/E ratio is 18.0x. The historical average is 32.8x. This places it at the 20th percentile of its historical range.

What is The Clorox Company's EV/EBITDA?

The Clorox Company's current EV/EBITDA is 8.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.7x.

What is The Clorox Company's ROE?

The Clorox Company's return on equity (ROE) is 159.9%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 122.1%.

Is CLX stock overvalued?

Based on historical data, The Clorox Company is trading at a P/E of 18.0x. This is at the 20th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is The Clorox Company's dividend yield?

The Clorox Company's current dividend yield is 4.93% with a payout ratio of 102.6%.

What are The Clorox Company's profit margins?

The Clorox Company has 42.3% gross margin and 24.7% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.

How much debt does The Clorox Company have?

The Clorox Company's Debt/EBITDA ratio is 2.9x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.